Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 4, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 4, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 178 Common Stock at $512.49 ($91,222) on August 4, 2026; holds 333,765 after (Indirect).
- Open-market sale: disposed of 182 Common Stock at $513.39 ($93,438) on August 4, 2026; holds 333,583 after (Indirect).
- Open-market sale: disposed of 675 Common Stock at $514.43 ($347,238) on August 4, 2026; holds 332,908 after (Indirect).
- Open-market sale: disposed of 605 Common Stock at $515.50 ($311,877) on August 4, 2026; holds 332,303 after (Indirect).
- Open-market sale: disposed of 2,456 Common Stock at $516.59 ($1,268,754) on August 4, 2026; holds 329,847 after (Indirect).
- Open-market sale: disposed of 3,142 Common Stock at $517.50 ($1,625,972) on August 4, 2026; holds 326,705 after (Indirect).
- Open-market sale: disposed of 1,446 Common Stock at $518.40 ($749,601) on August 4, 2026; holds 325,259 after (Indirect).
- Open-market sale: disposed of 517 Common Stock at $519.50 ($268,581) on August 4, 2026; holds 324,742 after (Indirect).
- Open-market sale: disposed of 299 Common Stock at $520.49 ($155,626) on August 4, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 4, 2026; holds 208,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,912,310 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-04 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-04 | Open-market sale | Common Stock | 178 | $512 | $91.2K | 333,765 |
| 2026-08-04 | Open-market sale | Common Stock | 182 | $513 | $93.4K | 333,583 |
| 2026-08-04 | Open-market sale | Common Stock | 675 | $514 | $347.2K | 332,908 |
| 2026-08-04 | Open-market sale | Common Stock | 605 | $515 | $311.9K | 332,303 |
| 2026-08-04 | Open-market sale | Common Stock | 2,456 | $517 | $1.3M | 329,847 |
| 2026-08-04 | Open-market sale | Common Stock | 3,142 | $517 | $1.6M | 326,705 |
| 2026-08-04 | Open-market sale | Common Stock | 1,446 | $518 | $749.6K | 325,259 |
| 2026-08-04 | Open-market sale | Common Stock | 517 | $519 | $268.6K | 324,742 |
| 2026-08-04 | Open-market sale | Common Stock | 299 | $520 | $155.6K | 324,443 |
| 2026-08-04 | Option exercise/conversion | Stock Option | 9,500 | — | — | 208,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-04 | Option exercise/conversion (9,500 shares) |
| 2026-08-04 | Open-market sale (178 shares) |
| 2026-08-04 | Open-market sale (182 shares) |
| 2026-08-04 | Open-market sale (675 shares) |
| 2026-08-04 | Open-market sale (605 shares) |
| 2026-08-04 | Open-market sale (2,456 shares) |
| 2026-08-04 | Open-market sale (3,142 shares) |
| 2026-08-04 | Open-market sale (1,446 shares) |
| 2026-08-04 | Open-market sale (517 shares) |
| 2026-08-04 | Open-market sale (299 shares) |
| 2026-08-04 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.